Ready or Not

At his blog, Neuroskeptic says broad-scale commercial fetal genome testing is "likely to become possible in the next few years." While researchers have already scanned fetal genomes to detect chromosomal abnormalities like Down syndrome, "those diseases are just the low-hanging fruit at the tip of the iceberg," Neuroskeptic says.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.